Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Hoffman

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
ACS Applied Materials & Interfaces|March 12, 2013
Monodisperse SnO2-coated gold nanoparticles are markedly more stable than analogous SiO2-coated gold nanoparticlesSang Ho Lee, Irene Rusakova, David M Hoffman, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 24, 2007
Relationship between GH-induced metabolic changes and changes in body composition: a dose and time course study in GH-deficient adultsMorton G Burt, James Gibney, David M Hoffman, et al.
Proceedings of Spie--The International Society for Optical Engineering|April 12, 2011
Stereo display with time-multiplexed focal adjustmentDavid M Hoffman, Philip J W Hands, Andrew K Kirby, et al.
Optics Express|September 3, 2009
High-speed switchable lens enables the development of a volumetric stereoscopic displayGordon D Love, David M Hoffman, Philip J W Hands, et al.
Cancer Chemotherapy and Pharmacology|March 29, 2017
Evaluation of the effect of the EGFR antibody-drug conjugate ABT-414 on QT interval prolongation in patients with advanced solid tumors likely to over-express EGFRWijith P Munasinghe, Rajendar K Mittapalli, Hong Li, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Temporal HbA1c patterns amongst patients with type 2 diabetes referred for specialist care: Data from the S4S-DINGO-Diabetes Informatics GroupTeresa Lam, David M Hoffman, Kimberly Cukier, et al.
Future Oncology (London, England)|July 19, 2022
Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemiaVladimir Ivanov, Su-Peng Yeh, Jiri Mayer, et al.
Clinical Pharmacokinetics|March 27, 2025
Pharmacokinetics and Safety of Navitoclax in Hepatic ImpairmentMaulik Patel, Jalaja Potluri, Thomas Marbury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I StudyKaren A Autio, Christopher A Klebanoff, David Schaer, et al.
Cancers|August 7, 2021
Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of OnsetCaroline Himbert, Jane C Figueiredo, David Shibata, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
ACS Applied Materials & Interfaces|March 12, 2013
Monodisperse SnO2-coated gold nanoparticles are markedly more stable than analogous SiO2-coated gold nanoparticlesSang Ho Lee, Irene Rusakova, David M Hoffman, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 24, 2007
Relationship between GH-induced metabolic changes and changes in body composition: a dose and time course study in GH-deficient adultsMorton G Burt, James Gibney, David M Hoffman, et al.
Proceedings of Spie--The International Society for Optical Engineering|April 12, 2011
Stereo display with time-multiplexed focal adjustmentDavid M Hoffman, Philip J W Hands, Andrew K Kirby, et al.
Optics Express|September 3, 2009
High-speed switchable lens enables the development of a volumetric stereoscopic displayGordon D Love, David M Hoffman, Philip J W Hands, et al.
Cancer Chemotherapy and Pharmacology|March 29, 2017
Evaluation of the effect of the EGFR antibody-drug conjugate ABT-414 on QT interval prolongation in patients with advanced solid tumors likely to over-express EGFRWijith P Munasinghe, Rajendar K Mittapalli, Hong Li, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Temporal HbA1c patterns amongst patients with type 2 diabetes referred for specialist care: Data from the S4S-DINGO-Diabetes Informatics GroupTeresa Lam, David M Hoffman, Kimberly Cukier, et al.
Future Oncology (London, England)|July 19, 2022
Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemiaVladimir Ivanov, Su-Peng Yeh, Jiri Mayer, et al.
Clinical Pharmacokinetics|March 27, 2025
Pharmacokinetics and Safety of Navitoclax in Hepatic ImpairmentMaulik Patel, Jalaja Potluri, Thomas Marbury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I StudyKaren A Autio, Christopher A Klebanoff, David Schaer, et al.
Cancers|August 7, 2021
Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of OnsetCaroline Himbert, Jane C Figueiredo, David Shibata, et al.
Pageof 3